secwatch.observer — SEC 8-K summary
======================================

Issuer:     ILLUMINA, INC. (ILMN)
CIK:        0001110803
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0001110803-25-000057
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Illumina Q2 EPS $1.19 non-GAAP, revenue $1.06B; raises FY2025 guidance
----------------------------------------------------------------------

- Revenue $1.059B down 3% YoY; GAAP EPS $1.49, non-GAAP EPS $1.19 vs. $1.09 prior year.
- FY2025 guidance raised: revenue decline (2.5%)-(0.5%), non-GAAP op margin 22%-22.5%, EPS $4.45-$4.55.
- Repurchased 4.5M shares for $380M at avg $84.66; ~$800M remaining authorization.
- Signed definitive agreement to acquire SomaLogic from Standard BioTools; close expected H1 2026.
- Q2 free cash flow $204M; cash and short-term investments $1.16B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1110803/000111080325000057/0001110803-25-000057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1110803/000111080325000057/ilmn-20250731.htm
  HTML page:      https://secwatch.observer/filing/0001110803-25-000057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer